Press "esc" to clear
Go to Advanced Search

Showing results

2130 of 103046

Article ID: 697688

Mount Sinai Health System and Business Council for International Understanding Co-Host Health Partnerships Roundtable

Mount Sinai Health System

Sir Malcolm Grant, Chairman of NHS England, and Mount Sinai leaders present health care solutions and opportunities

Released:
20-Jul-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
IMG_2223.JPG

Article ID: 697627

Sunday in the Park with AARDA!

American Autoimmune Related Diseases Association (AARDA)

3rd AARDA Walk in metro Detroit area will feature speakers, exhibitors, free screenings, a "Kid Zone", and a Warrior's Walk around Milliken State Park and Harbor on the RiverWalk to raise awareness and funding for patient services and research.

Released:
20-Jul-2018 6:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Education

Pharmacy-Students-Study-Away-Experiences.jpg

Article ID: 697680

UTEP Pharmacy Students Travel Outside their Comfort Zone, Learn Outside the Classroom

University of Texas at El Paso

This summer, UTEP School of Pharmacy students have been visiting recovering women addicts at a treatment center in Nashville, Tennessee, or standing on the Cliffs of Moher on the western coast of Ireland. Since March, dozens of students from the Doctor of Pharmacy program’s inaugural class at The University of Texas at El Paso have traveled across the country and overseas to engage in unique learning experiences designed to prepare future pharmacists to better serve diverse communities and cultures.

Released:
20-Jul-2018 5:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
7-20-18Paige.jpg
  • Embargo expired:
    20-Jul-2018 5:00 AM EDT

Article ID: 697636

Drug Now in Clinical Trials for Parkinson’s Strengthens Heart Contractions in Animals

Johns Hopkins Medicine

A drug currently in clinical trials for treating symptoms of Parkinson’s disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers.

Released:
19-Jul-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Indianwomanwithoxygen.jpg
  • Embargo expired:
    20-Jul-2018 12:15 AM EDT

Article ID: 697581

Supplemental Oxygen Eliminates Morning Blood Pressure Rise in Sleep Apnea Patients Following CPAP Withdrawal

American Thoracic Society (ATS)

Supplemental oxygen eliminates the rise in morning blood pressure experienced by obstructive sleep apnea (OSA) patients who stop using continuous positive airway pressure (CPAP), the standard treatment for OSA, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

Released:
18-Jul-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Embargo will expire:
23-Jul-2018 3:00 PM EDT
Released to reporters:
19-Jul-2018 8:00 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Jul-2018 3:00 PM EDT

Article ID: 697687

UW-Milwaukee Alumni Association Names 2018 Awardees

University of Wisconsin-Milwaukee

Two dozen distinguished individuals and one corporate partner will be honored by the UWM Alumni Association on Oct. 12, 2018. The eclectic, inspiring and accomplished list of awardees is now available.

Released:
19-Jul-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    19-Jul-2018 5:00 PM EDT

Article ID: 697392

Study Reveals Long-Term Effectiveness of Therapy for Common Cause of Kidney Failure

American Society of Nephrology (ASN)

• Among individuals with autosomal dominant polycystic kidney disease, those who were treated with tolvaptan for up to 11 years had a slower rate of kidney function decline compared with historical controls. • Annualized kidney function decline rates of tolvaptan-treated patients did not change during follow-up.

Released:
13-Jul-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Embargo will expire:
25-Jul-2018 4:00 PM EDT
Released to reporters:
19-Jul-2018 4:35 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Jul-2018 4:00 PM EDT

donhelme1v2.jpg

Article ID: 697679

UK Communication Professor Seeks Drug Disposal Solutions

University of Kentucky

UK researcher Don Helme is partnering with the Kentucky Attorney General’s office to gauge public opinion on a new drug deactivation pouch, part of a larger effort to develop solutions to the state’s opioid epidemic. Four counties have received Deterra, the deactivation pouch.

Released:
19-Jul-2018 4:15 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Social and Behavioral Sciences


Showing results

2130 of 103046





Chat now!